David DIN BELLE

SALT FORMS OF A 4H-PYRAN-4-ONE STRUCTURED CYP11 A1 INHIBITOR

CYP11A1 INHIBITORS

PYRAN DERIVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS

TEAD INHIBITORS

2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER

CYP11A1 INHIBITORS

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors

4,5-DIHYDROXY-2-(4-METHYLBENZYL)ISOPHTHALONITRILE SOLVATES AND CRYSTALLINE FORMS THEREOF

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

Catechol O-methyltransferase activity inhibiting compounds

2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases

2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases

2,3-DIHYDROBENZO(1,4) DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES

ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS

2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases

Polycyclic compounds as potent alpha2-adrenoceptor antagonists

Polycyclic compounds as potent alpha2-adrenoceptor antagonists